Cellarity
Sunil Kuppasani has accumulated extensive experience in the field of genomics, starting as a Genomics Scientist at Rutgers University from 2002 to 2014. Subsequently, they held roles at Bristol-Myers Squibb, including Research Scientist II and Senior Research Scientist I in Genomics from 2015 to 2020. Sunil currently serves as the Principal Scientist in Genomics at Cellarity from 2020 to present.
Sunil Kuppasani obtained a Bachelor of Science degree in Biotechnology from Osmania University. Sunil later pursued a Master's degree in Chemistry from Annamalai University.
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.